KIORA PHARMACEUTICALS, INC. Lease Incentive, Payable, Current
KIORA PHARMACEUTICALS, INC. (KPRX) had Lease Incentive, Payable, Current of $31.58 thousand as of 2016-09-30, per its 10-Q filed 2016-11-01.
Discontinued › Notes › Leases
us-gaap:LeaseIncentivePayableCurrent · last filed 2016-11-01
- 2016-09-30: Lease Incentive, Payable, Current $31.58K.
- 2015-12-31: Lease Incentive, Payable, Current $0.00.
| Period end | Lease Incentive, Payable, Current |
|---|---|
| 2016-09-30 | $31.58K 10-Q · filed 2016-11-01 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |